Opthea Limited (OPT)
NASDAQ: OPT · Real-Time Price · USD
3.340
+0.170 (5.37%)
Dec 20, 2024, 4:00 PM EST - Market closed
Opthea Revenue
In the fiscal year ending June 30, 2024, Opthea had annual revenue of $261.86K, down -32.03%. Opthea had revenue of $59.63K in the half year ending June 30, 2024, with 30.66% growth.
Revenue (ttm)
$261.86K
Revenue Growth
-32.03%
P/S Ratio
n/a
Revenue / Employee
$7,935
Employees
33
Market Cap
531.21M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Jun 30, 2024 | 261.86K | -123.42K | -32.03% |
| Jun 30, 2023 | 385.28K | 186.27K | 93.60% |
| Jun 30, 2022 | 199.01K | 103.44K | 108.24% |
| Jun 30, 2021 | 95.56K | -5.13K | -5.09% |
| Jun 30, 2020 | 100.69K | -136.12K | -57.48% |
| Jun 30, 2019 | Pro | Pro | Pro |
| Jun 30, 2018 | Pro | Pro | Pro |
| Jun 30, 2017 | Pro | Pro | Pro |
| Jun 30, 2016 | Pro | Pro | Pro |
| Jun 30, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Xeris Biopharma Holdings | 187.36M |
| Talkspace | 181.29M |
| Pacific Biosciences of California | 173.15M |
| Semler Scientific | 58.94M |
| Cartesian Therapeutics | 47.94M |
| EyePoint Pharmaceuticals | 45.71M |
| Mereo BioPharma Group | 1.00M |
OPT News
- 2 days ago - Opthea to Present at 43rd Annual J.P. Morgan Healthcare Conference - GlobeNewsWire
- 25 days ago - Opthea's Wet AMD Program to be Featured at FLORetina 2024 - GlobeNewsWire
- 5 weeks ago - Opthea Appoints Kathy Connell to Board of Directors - GlobeNewsWire
- 2 months ago - Opthea Wet AMD Program to be Presented at Innovate Retina - GlobeNewsWire
- 2 months ago - Opthea to Participate in the UBS Virtual Ophthalmology Day 2024 - GlobeNewsWire
- 3 months ago - Opthea Announces Completion of Drug Substance PPQ Campaign Validating Manufacturing Process of Sozinibercept - GlobeNewsWire
- 3 months ago - Opthea to Have Significant Presence at the 24ᵗʰ EURETINA Congress and EURETINA Innovation Spotlight - GlobeNewsWire
- 3 months ago - Opthea Announces Executive Leadership Changes and Senior Hires - GlobeNewsWire